Evaluation of cardiac function by magnetic resonance imaging during the follow-up of patients with Kawasaki disease

Circulation: Cardiovascular Imaging

Volumn 6, Issue 1, 2013, Pages 67-73

  Tacke, Carline E ^a   Romeih, Soha ^a   Kuipers, Irene M ^a   Spijkerboer, Anje M ^a   Groenink, Maarten ^a   Kuijpers, Taco W ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Cardiac function; Cardiac volume; Imaging; Kawasaki disease; Magnetic resonance imaging

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; BODY SURFACE; CARDIOVASCULAR MAGNETIC RESONANCE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; CORONARY ARTERY ANEURYSM; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HEART EJECTION FRACTION; HEART FUNCTION; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDSYSTOLIC VOLUME; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE FIBROSIS; HEART RIGHT VENTRICLE ENDDIASTOLIC VOLUME; HEART RIGHT VENTRICLE ENDSYSTOLIC VOLUME; HEART STROKE VOLUME; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; MYOCARDITIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; CHILD; COMPARATIVE STUDY; CORONARY ARTERY DISEASE; CORONARY BLOOD VESSEL; HEART; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE; METHODOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; REPRODUCIBILITY; RETROSPECTIVE STUDY;

ADOLESCENT; ADULT; CHILD; CORONARY ARTERY DISEASE; CORONARY VESSELS; FEMALE; FOLLOW-UP STUDIES; HEART; HUMANS; MAGNETIC RESONANCE IMAGING, CINE; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; MYOCARDIUM; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; STROKE VOLUME; VENTRICULAR FUNCTION, LEFT; YOUNG ADULT;

MLCS; MLOWN;

EID: 84874525453     PISSN: 19419651     EISSN: 19420080     Source Type: Journal    
DOI: 10.1161/CIRCIMAGING.112.976969     Document Type: Article

References (46)

1. Kawasaki T. Acute febrile mucocutaneous syndrome with lymphoid involvement with specifc desquamation of the fngers and toes in children [in Japanese]. Arerugi. 1967;16:178-222.
2. Newburger JW, Takahashi M, Burns JC, Beiser AS, Chung KJ, Duffy CE, Glode MP, Mason WH, Reddy V, Sanders SP. The treatment of Kawasaki syndrome with intravenous gamma globulin. N Engl J Med. 1986;315:341-347.
3. Newburger JW, Takahashi M, Gerber MA, Gewitz MH, Tani LY, Burns JC, Shulman ST, Bolger AF, Ferrieri P, Baltimore RS, Wilson WR, Baddour LM, Levison ME, Pallasch TJ, Falace DA, Taubert KA; Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Pediatrics. 2004;114:1708-1733.
4. Anderson TM, Meyer RA, Kaplan S. Long-term echocardiographic evaluation of cardiac size and function in patients with Kawasaki disease. Am Heart J. 1985;110(1 Pt 1):107-115.
5. Moran AM, Newburger JW, Sanders SP, Parness IA, Spevak PJ, Burns JC, Colan SD. Abnormal myocardial mechanics in Kawasaki disease: rapid response to gamma-globulin. Am Heart J. 2000;139(2 Pt 1):217-223.
6. Nakano H, Ueda K, Saito A, Nojima K. Left ventricular systolic function in children with coronary arterial lesion following Kawasaki disease. Heart Vessels. 1985;1:89-93.
7. Newburger JW, Sanders SP, Burns JC, Parness IA, Beiser AS, Colan SD. Left ventricular contractility and function in Kawasaki syndrome: effect of intravenous gamma-globulin. Circulation. 1989;79:1237-1246.
8. Hiraishi S, Yashiro K, Oguchi K, Kusano S, Ishii K, Nakazawa K. Clinical course of cardiovascular involvement in the mucocutaneous lymph node syndrome: relation between clinical signs of carditis and development of coronary arterial aneurysm. Am J Cardiol. 1981;47:323-330.
9. Matsuura H, Ishikita T, Yamamoto S, Umezawa T, Ito R, Hashiguchi R, Saji T, Matsuo N, Takano M. Gallium-67 myocardial imaging for the detection of myocarditis in the acute phase of Kawasaki disease (mucocu-taneous lymph node syndrome): the usefulness of single photon emission computed tomography. Br Heart J. 1987;58:385-392.
10. Kao CH, Hsieh KS, Wang YL, Chen CW, Liao SQ, Wang SJ, Yeh SH. Tc-99m HMPAO labeled WBC scan for the detection of myocarditis in different phases of Kawasaki disease. Clin Nucl Med. 1992;17:185-190.
11. Fujiwara H, Hamashima Y. Pathology of the heart in Kawasaki disease. Pediatrics. 1978;61:100-107.
12. Yutani C, Go S, Kamiya T, Hirose O, Misawa H, Maeda H, Kozuka T, Onishi S. Cardiac biopsy of Kawasaki disease. Arch Pathol Lab Med. 1981;105:470-473.
13. Pattynama PM, Lamb HJ, Van der Velde EA, Van der Geest RJ, Van der Wall EE, De Roos A. Reproducibility of MRI-derived measurements of right ventricular volumes and myocardial mass. Magn Reson Imaging. 1995;13:53-63.
14. Sakuma H, Fujita N, Foo TK, Caputo GR, Nelson SJ, Hartiala J, Shi-makawa A, Higgins CB. Evaluation of left ventricular volume and mass with breath-hold cine MR imaging. Radiology. 1993;188:377-380.
15. Van Rossum AC, Visser FC, Sprenger M, Van Eenige MJ, Valk J, Roos JP. Evaluation of magnetic resonance imaging for determination of left ventricular ejection fraction and comparison with angiography. Am J Cardiol. 1988;62:628-633.
16. Keenan NG, Pennell DJ. CMR of ventricular function. Echocardiography. 2007;24:185-193.
17. Kim RJ, Wu E, Rafael A, Chen EL, Parker MA, Simonetti O, Klocke FJ, Bonow RO, Judd RM. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med. 2000;343:1445-1453.
18. Mahrholdt H, Goedecke C, Wagner A, Meinhardt G, Athanasiadis A, Vogelsberg H, Fritz P, Klingel K, Kandolf R, Sechtem U. Cardiovascular magnetic resonance assessment of human myocarditis: a comparison to histology and molecular pathology. Circulation. 2004;109:1250-1258.
19. Research Committee on Kawasaki Disease. Report of the Subcommittee on Standardization of Diagnostic Criteria and Reporting of Coronary Artery Lesions in Kawasaki Disease. Tokyo, Japan: Ministry of Health and Welfare; 1984.
20. van der Geest RJ, Reiber JH. Quantifcation in cardiac MRI. J Magn Re-son Imaging. 1999;10:602-608.
21. Mewton N, Revel D, Bonnefoy E, Ovize M, Croisille P. Comparison of visual scoring and quantitative planimetry methods for estimation of global infarct size on delayed enhanced cardiac MRI and validation with myocar-dial enzymes. Eur J Radiol. 2011;78:87-92.
22. Cerqueira MD, Weissman NJ, Dilsizian V, Jacobs AK, Kaul S, Laskey WK, Pennell DJ, Rumberger JA, Ryan T, Verani MS; American Heart Association Writing Group on Myocardial Segmentation and Registration for Cardiac Imaging. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: a statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation. 2002;105:539-542.
23. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. 1986;1:307-310.
24. Wagner A, Mahrholdt H, Holly TA, Elliott MD, Regenfus M, Parker M, Klocke FJ, Bonow RO, Kim RJ, Judd RM. Contrast-enhanced MRI and routine single photon emission computed tomography (SPECT) perfusion imaging for detection of subendocardial myocardial infarcts: an imaging study. Lancet. 2003;361:374-379.
25. Hunold P, Schlosser T, Vogt FM, Eggebrecht H, Schmermund A, Bruder O, Schüler WO, Barkhausen J. Myocardial late enhancement in contrast-enhanced cardiac MRI: distinction between infarction scar and non-infarction-related disease. AJR Am J Roentgenol. 2005;184:1420-1426.
26. Tacke CE, Kuipers IM, Groenink M, Spijkerboer AM, Kuijpers TW. Cardiac magnetic resonance imaging for noninvasive assessment of cardiovascular disease during the follow-up of patients with Kawasaki disease. Circ Cardiovasc Imaging. 2011;4:712-720.
27. Yonesaka S, Takahashi T, Eto S, Sato T, Otani K, Ueda T, Sato A, Kitaga-wa Y, Konno Y, Kinjo M. Biopsy-proven myocardial sequels in Kawasaki disease with giant coronary aneurysms. Cardiol Young. 2010;20:602-609.
28. Mavrogeni S, Bratis K, Karanasios E, Georgakopoulos D, Kaklis S, Var-lamis G, Kolovou G, Douskou M, Papadopoulos G. CMR evaluation of cardiac involvement during the convalescence of Kawasaki disease. JACC Cardiovasc Imaging. 2011;4:1140-1141.
29. Greil GF, Stuber M, Botnar RM, Kissinger KV, Geva T, Newburger JW, Manning WJ, Powell AJ. Coronary magnetic resonance angiography in adolescents and young adults with Kawasaki disease. Circulation. 2002;105:908-911.
30. Mavrogeni S, Papadopoulos G, Douskou M, Kaklis S, Seimenis I, Baras P, Nikolaidou P, Bakoula C, Karanasios E, Manginas A, Cokkinos DV. Magnetic resonance angiography is equivalent to x-ray coronary angiography for the evaluation of coronary arteries in Kawasaki disease. J Am Coll Cardiol. 2004;43:649-652.
31. Mavrogeni S, Papadopoulos G, Douskou M, Kaklis S, Seimenis I, Varla-mis G, Karanasios E, Krikos X, Giannoulia A, Cokkinos DV. Magnetic resonance angiography, function and viability evaluation in patients with Kawasaki disease. J Cardiovasc Magn Reson. 2006;8:493-498.
32. Suzuki A, Takemura A, Inaba R, Sonobe T, Tsuchiya K, Korenaga T. Magnetic resonance coronary angiography to evaluate coronary arterial lesions in patients with Kawasaki disease. Cardiol Young. 2006;16:563-571.
33. Alfakih K, Plein S, Thiele H, Jones T, Ridgway JP, Sivananthan MU. Normal human left and right ventricular dimensions for MRI as assessed by turbo gradient echo and steady-state free precession imaging sequences. J Magn Reson Imaging. 2003;17:323-329.
34. Helbing WA, Rebergen SA, Maliepaard C, Hansen B, Ottenkamp J, Reiber JH, de Roos A. Quantifcation of right ventricular function with magnetic resonance imaging in children with normal hearts and with congenital heart disease. Am Heart J. 1995;130:828-837.
35. Lorenz CH, Walker ES, Morgan VL, Klein SS, Graham TP Jr. Normal human right and left ventricular mass, systolic function, and gender differences by cine magnetic resonance imaging. J Cardiovasc Magn Reson. 1999;1:7-21.
36. Maceira AM, Prasad SK, Khan M, Pennell DJ. Normalized left ventricular systolic and diastolic function by steady state free precession cardiovascular magnetic resonance. J Cardiovasc Magn Reson. 2006;8:417-426.
37. Maceira AM, Prasad SK, Khan M, Pennell DJ. Reference right ventricular systolic and diastolic function normalized to age, gender and body surface area from steady-state free precession cardiovascular magnetic resonance. Eur Heart J. 2006;27:2879-2888.
38. Marcus JT, DeWaal LK, Götte MJ, van der Geest RJ, Heethaar RM, Van Rossum AC. MRI-derived left ventricular function parameters and mass in healthy young adults: relation with gender and body size. Int J Card Imaging. 1999;15:411-419.
39. Robbers-Visser D, Boersma E, Helbing WA. Normal biventricular function, volumes, and mass in children aged 8 to 17 years. J Magn Reson Imaging. 2009;29:552-559.
40. Sandstede J, Lipke C, Beer M, Hofmann S, Pabst T, Kenn W, Neubauer S, Hahn D. Age-and gender-specifc differences in left and right ventricular cardiac function and mass determined by cine magnetic resonance imaging. Eur Radiol. 2000;10:438-442.
41. Tandri H, Daya SK, Nasir K, Bomma C, Lima JA, Calkins H, Bluemke DA. Normal reference values for the adult right ventricle by magnetic resonance imaging. Am J Cardiol. 2006;98:1660-1664.
42. Thiele H, Nagel E, Paetsch I, Schnackenburg B, Bornstedt A, Kouwenhoven M, Wahl A, Schuler G, Fleck E. Functional cardiac MR imaging with steady-state free precession (SSFP) signifcantly improves endocar-dial border delineation without contrast agents. J Magn Reson Imaging. 2001;14:362-367.
43. Winter MM, Bernink FJ, Groenink M, Bouma BJ, van Dijk AP, Helbing WA, Tijssen JG, Mulder BJ. Evaluating the systemic right ventricle by CMR: the importance of consistent and reproducible delineation of the cavity. J Cardiovasc Magn Reson. 2008;10:40.
44. Papavassiliu T, Kühl HP, Schröder M, Süselbeck T, Bondarenko O, Böhm CK, Beek A, Hofman MM, van Rossum AC. Effect of endocardial trabec-ulae on left ventricular measurements and measurement reproducibility at cardiovascular MR imaging. Radiology. 2005;236:57-64.
45. Gandy SJ, Waugh SA, Nicholas RS, Rajendra N, Martin P, Houston JG. MRI comparison of quantitative left ventricular structure, function and measurement reproducibility in patient cohorts with a range of clinically distinct cardiac conditions. Int J Cardiovasc Imaging. 2008;24:627-632.
46. de Zorzi A, Colan SD, Gauvreau K, Baker AL, Sundel RP, Newburger JW. Coronary artery dimensions may be misclassifed as normal in Kawasaki disease. J Pediatr. 1998;133:254-258.